Official UK procurement notice
Molecular Pathology Managed Service Market Engagement
Authority: University Hospitals Birmingham NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionUniversity Hospitals Birmingham NHS Foundation Trust (UHB) is seeking to engage with suppliers interested in its requirement for a Molecular Pathology Managed Service.
Suppliers who are able to offer solutions relevant to this requirement are invited to express an interest and attend a presentation day. Further details on how to do this are contained within the additional information section of this notice.
CPV: Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1University Hospitals Birmingham NHS Foundation Trust (UHB) is seeking to engage with…Planned
University Hospitals Birmingham NHS Foundation Trust (UHB) is seeking to engage with suppliers interested in its requirement for a Molecular Pathology Managed Service.
The Molecular Pathology Service at University Hospitals Birmingham (UHB) NHS Foundation Trust provides a comprehensive diagnostic service to internal users, as well as a large number of external users. The Department processes approximately 25,000 samples a year, the results of which are used for diagnostic and monitoring purposes and in conjunction with other clinical information to direct treatment.
Suppliers who are able to offer services relevant to this requirement are invited to express an interest and attend a presentation day. Further details on how to do this are contained within the additional information section of this notice.
This exercise is intended to provide potential bidders with the opportunity to review the Authority's Briefing Document and to provide information regarding the services they can offer that could meet these outline requirements. This builds on the Authority's commitment to engage with the market, by sharing information and seeking input from the market to enable us to develop the final specification and determine the appropriate route to market in a fair and transparent manner.
Procedure terms & legal framework
From the official record · publisher note attached- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Past planning notice
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 21 Oct 2022, 10:36 BST
- Last source update
- 21 Oct 2022, 10:36 BST
- FTS notice number
2022/S 000-029709- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0377b8Find a Tender
Publisher note: Potential suppliers are invited to provide a presentation for the pre-market engagement event to support the procurement of a Molecular Pathology Managed Service Contract on Monday 7 November 2022. This session will be a virtual session hosted via MS Teams. Suppliers wishing to participate in this market engagement exercise and express an interest in this requirement should respond via the online form on the Bravo Portal form by no later than 12:00 on 2 November 2022 Bravo reference of online form: “pqq__28704 - Molecular Pathology Managed Service Market Engagement” Direct link to response form: https://nhs.bravosolution.co.uk/go/048504250183F57E1D4F
How it was run
Official notice- Submission deadline
- —
Timeline
21 Oct 2022 → 1 Sept 2023 · 2 dates- Notice published21 Oct 2022, 10:36 BST
- Tender notice expected1 Sept 2023, 00:00 BST
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.